NHS Digital FHIR Implementation Guide (Retired - 2.1.50)

This guidance is under active development by NHS Digital and content may be added or updated on a regular basis.

vaccination-covid19-international

{
"resourceType": "Immunization",
"id": "bd2ec326-7570-46bd-98a0-02c4b924c79d",
{
"url": "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure",
"coding": [
{
"system": "http://snomed.info/sct",
"code": "1324681000000101",
"display": "Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)"
}
]
}
}
],
{
"system": "https://tools.ietf.org/html/rfc4122",
"value": "bd2ec326-7570-46bd-98a0-02c4b924c79d"
}
],
"status": "completed",
"coding": [
{
"system": "http://snomed.info/sct",
"code": "39114911000001105",
"display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
}
]
},
"patient": {
"reference": "Patient/1953684",
"type": "Patient",
"system": "https://fhir.nhs.uk/Id/nhs-number",
"value": "9912003888"
}
},
"occurrenceDateTime": "2020-12-23T13:00:08.476+00:00",
"recorded": "2020-12-23",
"primarySource": true,
"system": "urn:iso:std:iso:3166",
"value": "FR"
},
"display": "France"
},
"display": "DREAMLAND Pharmaceuticals Ltd"
},
"lotNumber": "4XR0",
"expirationDate": "2021-04-29",
"site": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "368208006",
"display": "Left upper arm structure (body structure)"
}
]
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "78421000",
"display": "Intramuscular route (qualifier value)"
}
]
},
"value": 1,
"unit": "pre-filled disposable injection",
"system": "http://snomed.info/sct",
"code": "3318611000001103"
},
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "443684005",
"display": "Disease outbreak (event)"
}
]
}
],
]
}
<Immunization xmlns="http://hl7.org/fhir">
<id value="bd2ec326-7570-46bd-98a0-02c4b924c79d" />
<extension url="https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure">
<system value="http://snomed.info/sct" />
<code value="1324681000000101" />
<display value="Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)" />
</coding>
</valueCodeableConcept>
</extension>
<system value="https://tools.ietf.org/html/rfc4122" />
<value value="bd2ec326-7570-46bd-98a0-02c4b924c79d" />
</identifier>
<status value="completed" />
<system value="http://snomed.info/sct" />
<code value="39114911000001105" />
<display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
</coding>
</vaccineCode>
<reference value="Patient/1953684" />
<type value="Patient" />
<system value="https://fhir.nhs.uk/Id/nhs-number" />
<value value="9912003888" />
</identifier>
</patient>
<occurrenceDateTime value="2020-12-23T13:00:08.476+00:00" />
<recorded value="2020-12-23" />
<primarySource value="true" />
<system value="urn:iso:std:iso:3166" />
<value value="FR" />
</identifier>
<display value="France" />
</location>
<display value="DREAMLAND Pharmaceuticals Ltd" />
</manufacturer>
<lotNumber value="4XR0" />
<expirationDate value="2021-04-29" />
<system value="http://snomed.info/sct" />
<code value="368208006" />
<display value="Left upper arm structure (body structure)" />
</coding>
</site>
<system value="http://snomed.info/sct" />
<code value="78421000" />
<display value="Intramuscular route (qualifier value)" />
</coding>
</route>
<value value="1" />
<unit value="pre-filled disposable injection" />
<system value="http://snomed.info/sct" />
<code value="3318611000001103" />
</doseQuantity>
<system value="http://snomed.info/sct" />
<code value="443684005" />
<display value="Disease outbreak (event)" />
</coding>
</reasonCode>
<doseNumberPositiveInt value="1" />
</protocolApplied>
</Immunization>
Immunization
back to top